treandahcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home | TREANDA® (bendamustine HCl) for |
| Description | Learn about another bendamustine HCI Important information for health care providers about TREANDA (bendamustine HCI) for Injection - official |
| Keywords | TREANDA chronic lymphocytic leukemia, TREANDA injection, TREANDA chronic lymphocytic leukemia treatment |
Server Information
| WebSite | |
| Host IP | 45.60.172.158 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
treandahcp.com Valuation
|
US$291,171
Last updated: 2023-05-14 17:27:42
treandahcp.com has Semrush global rank of 36,350,932. treandahcp.com has an estimated worth of US$ 291,171, based on its estimated Ads revenue. treandahcp.com receives approximately 33,597 unique visitors each day. Its web server is located in United States, with IP address 45.60.172.158. According to SiteAdvisor, treandahcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$291,171 |
| Daily Ads Revenue | US$269 |
| Monthly Ads Revenue | US$8,064 |
| Yearly Ads Revenue | US$96,759 |
| Daily Unique Visitors | 2,240 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| treandahcp.com. | A | 86400 | IP: 45.60.172.158 |
| treandahcp.com. | A | 86400 | IP: 45.60.152.158 |
| treandahcp.com. | NS | 86400 | NS Record: ns4.tevapharm.com. |
| treandahcp.com. | NS | 86400 | NS Record: ns3.tevapharm.com. |
| treandahcp.com. | NS | 86400 | NS Record: ns5.tevapharm.com. |
| treandahcp.com. | TXT | 86400 | TXT Record: v=spf1 -all |
| treandahcp.com. | TXT | 86400 | TXT Record: _globalsign-domain-verification=66ekzJeN9tFUQpGO7uyyoHHrdizHIYLS2HohhvJOl2 |
HtmlToTextCheckTime:2023-05-14 17:27:42
| Prescribing Information Important Safety Information Learn about another bendamustine HCI option Find out more Indications TREANDA is indicated for the treatment of patients with Chronic lymphocytic leukemia (CLL). Efficacy relative to first-line therapies other than chlorambucil has not been established. Indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Important Safety Information Contraindication: TREANDA is contraindicated in patients with a known hypersensitivity (e.g., anaphylactic and anaphylactoid reactions) to bendamustine. Myelosuppression: TREANDA caused severe myelosuppression (Grade 3-4) in 98% of patients in the two NHL studies. Three patients (2%) died from myelosuppression-related adverse reactions. Monitor leukocytes, platelets, hemoglobin (Hgb), and neutrophils frequently. Myelosuppression may require dose delays and/or subsequent dose reductions if recovery to the |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://www.treandahcp.com/ Content-Length: 0 Connection: close HTTP/2 200 cache-control: no-cache pragma: no-cache content-length: 12964 content-type: text/html; charset=utf-8 expires: -1 server: Microsoft-IIS/10.0 set-cookie: ASP.NET_SessionId=suqtured0cwu5qck44ssvzgi; path=/; HttpOnly; SameSite=Lax x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET arr-disable-session-affinity: true x-frame-options: DENY date: Thu, 23 Dec 2021 19:10:51 GMT set-cookie: visid_incap_2195910=3eyJhA2SSmSDdZUqRTp5ubzJxGEAAAAAQUIPAAAAAADfvn3Bjx7oDwVbE/Jt1hnf; expires=Fri, 23 Dec 2022 06:35:22 GMT; HttpOnly; path=/; Domain=.treandahcp.com set-cookie: nlbi_2195910=YUh1IUzNIjXU2tkxSAhktwAAAADkgUEcaMkB36shRmyPShgc; path=/; Domain=.treandahcp.com set-cookie: incap_ses_220_2195910=1S0CXJs56iBxVIxbTJkNA7zJxGEAAAAAzEaOPY8caYRqnToOHd7qXw==; path=/; Domain=.treandahcp.com x-cdn: Imperva x-iinfo: 11-24762892-24762893 NNNN CT(11 35 0) RT(1640286652556 0) q(0 0 1 0) r(1 1) U6 |
treandahcp.com Whois Information
Domain Name: TREANDAHCP.COM Registry Domain ID: 1731902470_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2021-06-30T23:07:43Z Creation Date: 2012-07-05T20:17:06Z Registry Expiry Date: 2022-07-05T20:17:06Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS3.TEVAPHARM.COM Name Server: NS4.TEVAPHARM.COM Name Server: NS5.TEVAPHARM.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-26T08:36:39Z <<< |